Selected article for: "docking study and global energy"

Author: Sovesh Mahapatra; Prathul Nath; Manisha Chatterjee; Neeladrisingha Das; Deepjyoti Kalita; Partha Roy; Soumitra Satapathi
Title: Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking
  • Document date: 2020_4_7
  • ID: m0q7rm6z_20
    Snippet: In our study, we have taken those drugs for docking purpose which show protease inhibition activity. The docking of SARS protein with the approved drug Saquinavir (DrugBank ID -DB01232), has a global energy of around -53.62eV which confirms that it had numerous steric clashes with the adjoining strands and thus highlight its potential to inhibit novel SARS coronavirus. Saquinavir is a small molecule antiretroviral drug (Figure 2b the author/funde.....
    Document: In our study, we have taken those drugs for docking purpose which show protease inhibition activity. The docking of SARS protein with the approved drug Saquinavir (DrugBank ID -DB01232), has a global energy of around -53.62eV which confirms that it had numerous steric clashes with the adjoining strands and thus highlight its potential to inhibit novel SARS coronavirus. Saquinavir is a small molecule antiretroviral drug (Figure 2b the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents